Immunofoco Presents a Novel In Vivo TCE Delivery Strategy Using Lentiviral Vectors at SITC 2026

Markets PR Newswire By PR Newswire 11 Nov 2026 12:52 1 min read
Immunofoco Presents a Novel In Vivo TCE Delivery Strategy Using Lentiviral Vectors at SITC 2026

SHANGHAI, Nov. 11, 2026 /PRNewswire/ -- At the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2026), held November 4–8 in Phoenix, Arizona, Immunofoco, in collaboration with Renji Hospital, Shanghai Jiao Tong University School of Medicine, and Shanghai East Hospital,...

Covered in this story

Call it yourself

No calls on $SITC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Site Centers Corp →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.